Clik here to view.
和铂医药与Glenmark Pharmaceuticals签署同类首创双特异性抗体药物战略合作与独家授权协议
中国上海，美国波士顿，印度孟买和瑞士La Chaux de Fonds (美国商业资讯)–全球化的生物制药公司和铂医药与Glenmark Pharmaceuticals S.A. 宣布签署一项独家授权协议，在大中华区开发、生产以及商业化GBR 1302。这是一种由Glenmark开发的用于治疗HER2阳性癌症的靶向HER2和CD3的双特异性抗体创新药物。...
View ArticleClik here to view.
Harbour BioMed and Glenmark Pharmaceuticals Sign Agreement for Greater China...
BOSTON & SHANGHAI & MUMBAI, India & LA CHAUX DE FONDS, Switzerland Harbour BioMed and Glenmark Pharmaceuticals S.A., announced today that they have entered into an exclusive license...
View ArticleClik here to view.
PaceMate™ Partners with SeaMercy on Pacific Islands Healthcare Mission
BRADENTON, Fla. PaceMateTM announces today the volunteer partnership between CEO Kevin R. Campbell, MD, FACC, and SeaMercy, an Oregon-based charity committed to providing medical relief to...
View ArticleClik here to view.
Can-Fite Receives from CMS Medical Venture Investment Limited $2,000,000...
PETACH TIKVA, Israel Can-Fite BioPharma Ltd. (NYSE American:CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address cancer, liver and...
View ArticleClik here to view.
Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class...
REDWOOD CITY, Calif. & OSAKA, Japan Ambys Medicines, a biotechnology company focused on the discovery and development of transformative therapies for people with serious liver disease, and...
View ArticleClik here to view.
Genome Editing Biotech Company EdiGene Raises $15 Million in Series pre-B...
BEIJING & CAMBRIDGE, Mass. EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery,...
View ArticleClik here to view.
Glen Richards-Backed Healthia Limited to List on the ASX$26.8m Initial Public...
BRISBANE, Australia Healthia Limited (Healthia or the Company), is aiming to become one of Australia’s leading allied health companies offering podiatry, physiotherapy and related services, with the...
View ArticleClik here to view.
AVITA Medical Announces Expanded Compassionate Use of RECELL® Device in...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that the U.S. Food and Drug Administration (FDA) has approved a significant increase in the number...
View ArticleClik here to view.
STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic...
MONROVIA, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, and Dr. Maro Kariya of...
View ArticleClik here to view.
AVEO Announces Acceptance of CANbridge Investigational New Drug Application...
CAMBRIDGE, Mass. AVEO Oncology (Nasdaq: AVEO) today announced that the China National Drug Administration (CNDA) has accepted CANbridge Life Sciences’ Investigational New Drug (IND) Application for...
View ArticleClik here to view.
CANbridge Life Sciences Receives Approval to Commence CAN017 Ib/III Trial in...
BEIJING CANbridge Life Sciences, a biopharmaceutical company developing Western drug candidates in China and North Asia, announced that the China National Drug Administration (CNDA) has approved the...
View ArticleClik here to view.
Harbour BioMed Announces Global Strategic Partnership with Kelun-Biotech to...
SHANGHAI & CHENGDU, China & BOSTON & CRANBURY, N.J. Harbour BioMed today announced it has entered into an exclusive strategic partnership with Sichuan Kelun-Biotech Biopharmaceutical...
View ArticleClik here to view.
Clik here to view.
Vertex Receives a Positive PBAC Recommendation for Reimbursement of ORKAMBI®...
LONDON Vertex Pharmaceuticals (Europe) Limited announces that it has received the Pharmaceutical Benefits Advisory Committee’s (PBAC) recommendation for ORKAMBI® (lumacaftor/ivacaftor) to be listed...
View ArticleClik here to view.
Therabiopharma (Japan Based Bio-Venture) Reports 10,000 Times Higher Curcumin...
KAWASAKI, Japan Therabiopharma, a Japan based bio-venture, reports that CMG(Curcumin Monoglucuronide) has proven: This press release features multimedia. View the full release here:...
View ArticleClik here to view.
AVITA Medical Announces Presentation of RECELL® Device Effectiveness and...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that results from two U.S. pivotal clinical trials demonstrating the effectiveness and clinical...
View ArticleClik here to view.
领先的全球医疗综合通信技术公司HEX Innovation启动代币销售
香港 (美国商业资讯)–领先的全球医疗综合通信技术(ICT)公司HEX Innovation Ltd宣布于8月22日启动代币销售。其代币销售将为进一步建设医疗生态系统筹资。 HEX的私人销售从8月初开始，将持续到8月底。从9月1日开始，将通过首次代币发行(ICO)公开启动HEX。公司将尽快公布加密货币众筹的详细时间表。在启动之后，HEX计划开展进一步空投并在各个加密货币交易所上市HEX。...
View ArticleClik here to view.
Gynesonics Receives FDA Clearance to Market Sonata® System
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that it has received 510(k)...
View ArticleClik here to view.
Pfizer and Astellas Amend Clinical Research Protocols for Two Phase 3 Trials...
NEW YORK & TOKYO Pfizer Inc. (NYSE:PFE) and Astellas Pharma Inc. (TSE:4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced amendments to the protocols for two...
View ArticleClik here to view.
AVITA Medical Announces Commencement of Manufacturing of RECELL® Device in...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced the successful completion of multiple production runs for the RECELL Device® within its newly...
View Article